Prospect Venture Partners logo

Prospect Venture Partners

North America, California, United States, Palo Alto

Description

Prospect Venture Partners is a Palo Alto, California based venture capital firmwith over $1B of capital under management.

Investor Profile

Prospect Venture Partners has backed more than 88 startups, with 0 new investments in the last 12 months alone. The firm has led 18 rounds, about 20% of its total and boasts 24 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series C rounds (top funding stages).
  • Majority of deals are located in United States, Belgium.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series B (34%)
  • Series A (18%)
  • Series C (17%)
  • Series D (14%)
  • Series Unknown (11%)
  • Series E (2%)
  • Post Ipo Equity (1%)
  • Series G (1%)
  • Series F (1%)

Country Focus

  • United States (99%)
  • Belgium (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Medical Device
  • Therapeutics
  • Biopharma
  • Genetics
  • Life Science
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Prospect Venture Partners frequently co-invest with?

Sutter Hill Ventures
North America, California, United States, Palo Alto
Co-Investments: 6
Three Arch Partners
North America, California, United States, Portola Valley
Co-Investments: 8
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 11
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 11
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 8
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 6
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 7
Rho Ventures
North America, New York, United States, New York
Co-Investments: 6
Venrock
North America, California, United States, Palo Alto
Co-Investments: 15
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 7

Which angels does Prospect Venture Partners often collaborate with?

SP
Europe, Germany
Shared Deals: 1
FM
North America, United States
Shared Deals: 1
SH
North America, New Hampshire, United States, Center Harbor
Shared Deals: 1

What are some of recent deals done by Prospect Venture Partners?

SentreHEART

Redwood City, California, United States

SentreHEART is a medical device company developing tissue closure solutions, offering physicians control over remotely delivered sutures.

Health CareMedicalMedical Device
Series DSep 27, 2016
Amount Raised: $35,000,000
NGM Biopharmaceuticals

South San Francisco, California, United States

NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.

BiopharmaBiotechnologyGeneticsMedical
Series DMar 23, 2015
Amount Raised: $57,500,000
Nora Therapeutics

Palo Alto, California, United States

Nora Therapeutics is a specialty biopharmaceutical company developing therapeutics to address clinical unmet needs in reproductive medicine.

BiotechnologyHealth CareMedical Device
Series BApr 17, 2014
Amount Raised: $18,000,000
Element Science

San Francisco, California, United States

Element Science is a medical device and digital health start-up that develops lifesaving wearable solutions.

BiotechnologyHealth CareMedicalMedical DeviceWearables
Series AMar 19, 2014
Amount Raised: $12,500,000
NinePoint Medical

Cambridge, Massachusetts, United States

NinePoint Medical is a transformational medical device company developing innovative, real-time, in vivo pathology devices.

Health CareMedicalMedical Device
Series BMar 18, 2014
Amount Raised: $34,000,000
NGM Biopharmaceuticals

South San Francisco, California, United States

NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.

BiopharmaBiotechnologyGeneticsMedical
Series CJul 18, 2013
Amount Raised: $50,000,000
SentreHEART

Redwood City, California, United States

SentreHEART is a medical device company developing tissue closure solutions, offering physicians control over remotely delivered sutures.

Health CareMedicalMedical Device
Series CJun 4, 2012
Amount Raised: $26,000,000
Satori Pharmaceuticals

Cambridge, Massachusetts, United States

Satori Pharmaceuticals develops disease-modifying therapies for alzheimer's, parkinson's and other neurodegenerative disorders.

Health CareNeurosciencePharmaceutical
Series UnknownFeb 23, 2012
Amount Raised: $15,000,000
DFine

San Jose, California, United States

DFine is a medical device company that develops therapeutic devices to manage compression fractures of the spine.

Health CareMedical DeviceTherapeutics
Series UnknownNov 8, 2011
Amount Raised: $25,000,000
Topica Pharmaceuticals

Palo Alto, California, United States

TOPICA Pharmaceuticals is a clinical research stage company focused on developing topical treatment for fungal infections of the nail.

BiotechnologyMedical DevicePharmaceutical
Series BOct 18, 2011
Amount Raised: $27,000,000

Find More Investors Like Prospect Venture Partners

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Prospect Venture Partners | Pipeseed